The Importance of Co-testing in Cervical Cancer Screening
APRIL 6, 2021
11 am PT ǀ 12 pm MT ǀ 1 pm CT ǀ 2 pm ET
Presented by Michael D. Randell, M.D., F.A.C.O.G., Emory Saint Joseph's Hospital
Duration: 1 hour
1 hour CE credit (ACCME, ANCC, APA, CCHP, ADA)
Made possible by an educational grant from Hologic, Inc.
In this session we will discuss the improved safety and effectiveness of Pap+HPV (co-testing) using real world data reflective of current clinical practice in the U.S. We will explore further into background, guidelines, data, and advocacy concerns.
About the Presenter
Michael D. Randell, M.D., F.A.C.O.G. is an award winning Board Certified Obstetrician and Gynecologist in private practice in Atlanta, Georgia. Dr. Randell is on the Medical Staff at Emory Saint Joseph's Hospital in the Department of Gynecology.
Born in Miami, Florida, Dr. Randell earned his Bachelor of Science degree from Emory University in Atlanta and received his Medical degree with research distinction from the University of Miami School of Medicine in Miami. He completed an internship and residency in Obstetrics and Gynecology at the University of Miami/Jackson Memorial Medical Center. He is well trained in advanced laparoscopic surgery and robotics.
His research interests in managing cancer during pregnancy, the effects of barometric pressure changes on the initiation of labor, and the treatment of atypical Pap smears have led to award winning presentations at scientific meetings. Dr. Randell is regularly invited to speak at national medical conferences and is frequently interviewed by the news media on issues related to women’s health care.
Dr. Randell is a Diplomate of the American Board of Obstetrics and Gynecology and the National Board of Medical Examiners. He is also a Fellow of the American College of Obstetricians and Gynecologists. Dr. Randell has been selected by the Atlanta Medical Community as a “Top Doctor.”